← Back to Dividend Calendar

Novartis AG ADR

NVSNYSE

HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Market Cap

$309.52B

Revenue (TTM)

$56.67B

EBITDA

$23.47B

Profit Margin

24.7%

P/E Ratio

22.52

Earnings Growth (YoY)

-11.6%

Return on Equity

30.8%

Dividend Yield

3.0%

Upcoming Events (1)Past Events (0)

Earnings Report

Novartis

Pre-Market

Report Date:

Fiscal Period:

EPS Estimate:

Rev. Estimate:

Price Target:

Oct 27, 2026

Q3 2026

$2.25(prior yr: $2.25)

$14.6B

$158.73